Article Sidebar

PDF
Date Published: 28/08/2025
Abstract Views: 22
Views PDF: 18
DOI: https://doi.org/10.56535/jmpm.v50i6.1204
Issue
Vol. 50 No. 6 (2025): TẠP CHÍ Y DƯỢC HỌC QUÂN SỰ SỐ 6 - 2025
Section
Articles
How to Cite
Nguyễn Khánh, V., Nguyễn Xuân, H., Phạm Thuý, H., Nguyễn Văn, Q., & Hiếu, L. T. (2025). RESULTS OF HEPATECTOMY FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA AT THONG NHAT HOSPITAL. Journal of Military Pharmaco-medicine, 50(6), 248-255. https://doi.org/10.56535/jmpm.v50i6.1204

RESULTS OF HEPATECTOMY FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA AT THONG NHAT HOSPITAL

Vân Nguyễn Khánh1, Hoà Nguyễn Xuân1, Hằng Phạm Thuý1, Quỳnh Nguyễn Văn2, Lê Trung Hiếu3,
1 Khoa Ngoại Gan Mật, Bệnh viện Thống Nhất
2 Đơn vị Phẫu thuật Gan - Mật - Tụy, Khoa Ngoại bụng, Bệnh viện Quân y 175
3 Bệnh viện Trung ương Quân đội 108

Main Article Content

Abstract

Objectives: To evaluate the early results of anatomical hepatectomy in treating hepatocellular carcinoma. Methods: A retrospective, descriptive study was conducted on 73 cases who underwent anatomical hepatectomy to treat hepatocellular carcinoma at Thong Nhat Hospital from August 2022 to August 2024. Result: The average age was 63.1 ± 17.5 years old, 72.6% were males. The incidence of viral hepatitis (B or C) was 65.8%. Increased AFP concentration accounted for 63.0%. The average number of tumors was 1.3 ± 0.3. The average tumor size was 4.3 ± 1.4cm. 87.7% of patients had two or more liver segments removed. The mean operation time was 253.2 ± 58.3 minutes; the mean blood loss was 215.6 ± 72.3mL. The average length of postoperative hospital stay was 12.2 ± 5.6 days. Postoperative complications (23.3%) included liver failure (1.4%), bleeding (2.7%), bile leak (2.7%), surgical wound infection (6.8%), pneumonia (1.4%), and pleural effusion (9.5%). Conclusion: Anatomical hepatectomy for the treatment of hepatocellular carcinoma is safe and feasible. It is necessary to monitor and evaluate the long-term outcomes of patients.

Article Details

Keywords

Anatomical hepatectomy, Hepatocellular carcinoma, Hepatitis B

References

1. Rajesh Sharma. Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: Evidence from GLOBOCAN 2018. Japanese Journal of Clinical Oncology. 2020; 50:1370-1379.
2. Vũ Văn Quang. Nghiên cứu ứng dụng kỹ thuật kiểm soát cuống glisson theo Takasaki trong cắt gan điều trị ung thư biểu mô tế bào gan tại Bệnh viện Trung ương Quân đội 108. Viện Nghiên cứu Khoa học Y Dược học lâm sàng 108. 2018.
3. Lê Văn Thành. Kết quả cắt gan theo giải phẫu điều trị ung thư biểu mô tế bào gan tại Bệnh viện Trung ương Quân đội 108. Tạp chí Y học Việt Nam. 2023; 526:234-238.
4. Chia-Yen Dai. Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resection. Journal of the Chinese Medical Association. 2018; 81:155-163.
5. HB ES. Hepatocellular carcinoma. N Engl J Med. 2011; 365:1118-1127.
6. Davila JA. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: A population- based study. Gastroenterology. 2004; 127:1372-1380.
7. Ahmed Shehta. Impact of tumor size on the outcomes of hepatic resection for hepatocellular carcinoma: A retrospective study. BMC Surgery. 2024; 24.
8. Fabrizio Romano. Bleeding in Hepatic Surgery: Sorting through. HPB Surgery. 2012; 12:12.
9. H-W Xu. Outcomes following laparoscopic versus open major hepatectomy for hepatocellular carcinoma in patients with cirrhosis: A propensity score-matched analysis. Surgical Endoscopy. 2017; 32:712-719.
10. Takahara. Comparison of laparoscopic major hepatectomy with propensity score matched open cases from the National Clinical Database in Japan. Journal of Hepato‐Biliary‐Pancreatic Science. 2016; 23:721-734.